BOT 6.15% 34.5¢ botanix pharmaceuticals ltd

Ann: Trading Halt, page-281

  1. 260 Posts.
    lightbulb Created with Sketch. 120
    Kaken had an existing distribution team, BOT needs to start hiring, then train, and that's before they even start selling, I think we need to curb the near term enthusiasm. Long term I don't disagree there's a lot of potential, but things always takes much longer than the smooth sailing scenario that we all desperately want to gravitate towards. Maybe assume Kaken's year 1 is our year 2, and use a 1.5x multiplier instead of 3x population for conservatism (refill is another separate factor too I get it). Just not sure it's in anyone's interest to get overly excited and then be disappointed, and end up blaming management for their own overly optimistic forecasts which was never there in the first place.
 
watchlist Created with Sketch. Add BOT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.